Table 2

Levels of serum miRNAs (mean ± SD), PG (median ± SD) between different gastric disease groups
Variables CON AG GC P-value
miR-20a-5p 3.77 ± 0.74 3.84 ± 0.69 3.83 ± 0.68 0.581
Male 3.80 ± 0.77 3.90 ± 0.73 3.88 ± 0.78 0.59
Female 3.72 ± 0.69 3.73 ± 0.60 3.75 ± 0.47 0.855
let-7a 3.72 ± 0.34 3.77 ± 0.29 3.75 ± 0.28 0.445
Male 3.72 ± 0.31 3.78 ± 0.32 3.77 ± 0.28 0.367
Female 3.71 ± 0.39 3.76 ± 0.24 3.72 ± 0.28 0.93
miR-320a 4.99 ± 0.46 4.94 ± 0.45 4.90 ± 0.44 0.152
Male 5.03 ± 0.49 5.01 ± 0.46 5.00 ± 0.42 0.76
Female 4.93 ± 0.40 4.81 ± 0.39 4.73 ± 0.43 0.035*
PGA 146.3 ± 101.5 111.0 ± 85.4 130.1 ± 107.1 0.044§
PGC 19.2 ± 17.6 14.0 ± 12.2 23.1 ± 23.0 0.003§
PGA/PGC 9.52 ± 4.85 9.52 ± 5.23 7.86 ± 5.46 0.039§

P*:GC vs Control; P§:difference among the three groups. CON: Cases with minimal superficial gastritis were treated as the controls; AG: atrophic gastritis; GC: gastric cancer.

Xu et al.

Xu et al. BMC Clinical Pathology 2013 13:11   doi:10.1186/1472-6890-13-11

Open Data